Receptors, Fibroblast Growth Factor
"Receptors, Fibroblast Growth Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites or structures on cell membranes that react with FIBROBLAST GROWTH FACTORS (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity.
Descriptor ID |
D017468
|
MeSH Number(s) |
D12.776.543.750.750.400.370
|
Concept/Terms |
Receptors, Fibroblast Growth Factor- Receptors, Fibroblast Growth Factor
- Receptors, FGF
- Fibroblast Growth Factor Receptor
- Fibroblast Growth Factor Receptors
- FGF Receptor
- Receptor, FGF
- FGF Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Fibroblast Growth Factor".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Fibroblast Growth Factor".
- Receptors, Fibroblast Growth Factor
- Receptor, Fibroblast Growth Factor, Type 1
- Receptor, Fibroblast Growth Factor, Type 2
- Receptor, Fibroblast Growth Factor, Type 3
- Receptor, Fibroblast Growth Factor, Type 4
- Receptor, Fibroblast Growth Factor, Type 5
This graph shows the total number of publications written about "Receptors, Fibroblast Growth Factor" by people in this website by year, and whether "Receptors, Fibroblast Growth Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2017 | 2 | 1 | 3 |
2018 | 2 | 2 | 4 |
2019 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Fibroblast Growth Factor" by people in Profiles.
-
Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design. J Med Chem. 2019 08 22; 62(16):7473-7488.
-
Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction. Cardiovasc Pathol. 2019 May - Jun; 40:47-54.
-
Emerging Structure-Function Paradigm of Endocrine FGFs in Metabolic Diseases. Trends Pharmacol Sci. 2019 02; 40(2):142-153.
-
FGF Family: From Drug Development to Clinical Application. Int J Mol Sci. 2018 Jun 26; 19(7).
-
Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors. Eur J Med Chem. 2018 Jun 25; 154:9-28.
-
Structural Characterization of the Interaction of the Fibroblast Growth Factor Receptor with a Small Molecule Allosteric Inhibitor. Chemistry. 2018 Jun 04; 24(31):7861-7865.
-
Heat shock protein (Hsp) regulation by muscarinic acetylcholine receptor (mAChR) activation in the rat hippocampus. J Cell Physiol. 2018 08; 233(8):6107-6116.
-
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models. Acta Pharmacol Sin. 2018 Feb; 39(2):243-250.
-
Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Rep. 2017 08 15; 20(7):1717-1728.
-
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer. Expert Opin Investig Drugs. 2017 May; 26(5):551-561.